Mecp2-null mice provide new neuronal targets for Rett syndrome.

BACKGROUND: Rett syndrome (RTT) is a complex neurological disorder that is one of the most frequent causes of mental retardation in women. A great landmark in research in this field was the discovery of a relationship between the disease and the presence of mutations in the gene that codes for the m...

Full description

Bibliographic Details
Main Authors: Rocio G Urdinguio, Lidia Lopez-Serra, Pilar Lopez-Nieva, Miguel Alaminos, Ramon Diaz-Uriarte, Agustin F Fernandez, Manel Esteller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2008-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC2576441?pdf=render
_version_ 1819068204885999616
author Rocio G Urdinguio
Lidia Lopez-Serra
Pilar Lopez-Nieva
Miguel Alaminos
Ramon Diaz-Uriarte
Agustin F Fernandez
Manel Esteller
author_facet Rocio G Urdinguio
Lidia Lopez-Serra
Pilar Lopez-Nieva
Miguel Alaminos
Ramon Diaz-Uriarte
Agustin F Fernandez
Manel Esteller
author_sort Rocio G Urdinguio
collection DOAJ
description BACKGROUND: Rett syndrome (RTT) is a complex neurological disorder that is one of the most frequent causes of mental retardation in women. A great landmark in research in this field was the discovery of a relationship between the disease and the presence of mutations in the gene that codes for the methyl-CpG binding protein 2 (MeCP2). Currently, MeCP2 is thought to act as a transcriptional repressor that couples DNA methylation and transcriptional silencing. The present study aimed to identify new target genes regulated by Mecp2 in a mouse model of RTT. METHODOLOGY/PRINCIPAL FINDINGS: We have compared the gene expression profiles of wild type (WT) and Mecp2-null (KO) mice in three regions of the brain (cortex, midbrain, and cerebellum) by using cDNA microarrays. The results obtained were confirmed by quantitative real-time PCR. Subsequent chromatin immunoprecipitation assays revealed seven direct target genes of Mecp2 bound in vivo (Fkbp5, Mobp, Plagl1, Ddc, Mllt2h, Eya2, and S100a9), and three overexpressed genes due to an indirect effect of a lack of Mecp2 (Irak1, Prodh and Dlk1). The regions bound by Mecp2 were always methylated, suggesting the involvement of the methyl-CpG binding domain of the protein in the mechanism of interaction. CONCLUSIONS: We identified new genes that are overexpressed in Mecp2-KO mice and are excellent candidate genes for involvement in various features of the neurological disease. Our results demonstrate new targets of MeCP2 and provide us with a better understanding of the underlying mechanisms of RTT.
first_indexed 2024-12-21T16:30:26Z
format Article
id doaj.art-f5f617b30532421da8549fe8ae2c94ee
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T16:30:26Z
publishDate 2008-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-f5f617b30532421da8549fe8ae2c94ee2022-12-21T18:57:22ZengPublic Library of Science (PLoS)PLoS ONE1932-62032008-01-01311e366910.1371/journal.pone.0003669Mecp2-null mice provide new neuronal targets for Rett syndrome.Rocio G UrdinguioLidia Lopez-SerraPilar Lopez-NievaMiguel AlaminosRamon Diaz-UriarteAgustin F FernandezManel EstellerBACKGROUND: Rett syndrome (RTT) is a complex neurological disorder that is one of the most frequent causes of mental retardation in women. A great landmark in research in this field was the discovery of a relationship between the disease and the presence of mutations in the gene that codes for the methyl-CpG binding protein 2 (MeCP2). Currently, MeCP2 is thought to act as a transcriptional repressor that couples DNA methylation and transcriptional silencing. The present study aimed to identify new target genes regulated by Mecp2 in a mouse model of RTT. METHODOLOGY/PRINCIPAL FINDINGS: We have compared the gene expression profiles of wild type (WT) and Mecp2-null (KO) mice in three regions of the brain (cortex, midbrain, and cerebellum) by using cDNA microarrays. The results obtained were confirmed by quantitative real-time PCR. Subsequent chromatin immunoprecipitation assays revealed seven direct target genes of Mecp2 bound in vivo (Fkbp5, Mobp, Plagl1, Ddc, Mllt2h, Eya2, and S100a9), and three overexpressed genes due to an indirect effect of a lack of Mecp2 (Irak1, Prodh and Dlk1). The regions bound by Mecp2 were always methylated, suggesting the involvement of the methyl-CpG binding domain of the protein in the mechanism of interaction. CONCLUSIONS: We identified new genes that are overexpressed in Mecp2-KO mice and are excellent candidate genes for involvement in various features of the neurological disease. Our results demonstrate new targets of MeCP2 and provide us with a better understanding of the underlying mechanisms of RTT.http://europepmc.org/articles/PMC2576441?pdf=render
spellingShingle Rocio G Urdinguio
Lidia Lopez-Serra
Pilar Lopez-Nieva
Miguel Alaminos
Ramon Diaz-Uriarte
Agustin F Fernandez
Manel Esteller
Mecp2-null mice provide new neuronal targets for Rett syndrome.
PLoS ONE
title Mecp2-null mice provide new neuronal targets for Rett syndrome.
title_full Mecp2-null mice provide new neuronal targets for Rett syndrome.
title_fullStr Mecp2-null mice provide new neuronal targets for Rett syndrome.
title_full_unstemmed Mecp2-null mice provide new neuronal targets for Rett syndrome.
title_short Mecp2-null mice provide new neuronal targets for Rett syndrome.
title_sort mecp2 null mice provide new neuronal targets for rett syndrome
url http://europepmc.org/articles/PMC2576441?pdf=render
work_keys_str_mv AT rociogurdinguio mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT lidialopezserra mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT pilarlopeznieva mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT miguelalaminos mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT ramondiazuriarte mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT agustinffernandez mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome
AT manelesteller mecp2nullmiceprovidenewneuronaltargetsforrettsyndrome